Related Experiment Video
Updated: Jun 29, 2025

09:32
Generation of Induced Pluripotent Stem Cells from Human Peripheral T Cells Using Sendai Virus in Feeder-free Conditions
Published on: November 11, 2015
12.0K
Transgene-Free Cynomolgus Monkey iPSCs Generated under Chemically Defined Conditions
Yuliia Tereshchenko1,2, Nesil Esiyok1, Enrique Garea-Rodríguez3
1Research Platform Degenerative Diseases, German Primate Center-Leibniz Institute for Primate Research, Kellnerweg 4, 37077 Göttingen, Germany.
Cells
|March 27, 2024
Summary
Researchers generated new transgene- and feeder-free cynomolgus monkey induced pluripotent stem cells (iPSCs). These cynomolgus monkey iPSCs (Cyno-iPSCs) can differentiate into cardiomyocytes and neurons, advancing cell replacement therapy research.
Area of Science:
- Stem Cell Biology
- Translational Medicine
- Non-human Primate Models
Background:
- Non-human primates (NHPs) are crucial for preclinical testing of cell replacement therapies.
- Generating high-quality NHP induced pluripotent stem cells (iPSCs) is essential for allogeneic transplantation studies.
- Existing NHP iPSC lines need expansion for broader translational applications.
Purpose of the Study:
- To generate and characterize novel transgene- and feeder-free cynomolgus monkey iPSCs (Cyno-iPSCs).
- To establish a reliable NHP iPSC resource for preclinical research and cell therapy development.
- To demonstrate the differentiation potential of Cyno-iPSCs into clinically relevant cell types.
Main Methods:
- Generation of cynomolgus monkey iPSCs using a refined protocol.
- Characterization of Cyno-iPSCs for pluripotency markers and quality.
- Differentiation assays to assess cardiomyocyte and neuron generation from Cyno-iPSCs.
Main Results:
- Successfully generated transgene- and feeder-free Cyno-iPSCs from *Macaca fascicularis*.
- Confirmed pluripotency and quality of the novel Cyno-iPSC lines.
- Demonstrated successful differentiation into cardiomyocytes and neurons.
Conclusions:
- Novel Cyno-iPSCs provide a valuable resource for preclinical research in regenerative medicine.
- These iPSCs are suitable for allogeneic transplantation studies in NHPs, mirroring human applications.
- Expansion of NHP iPSC models facilitates the translation of cell-based therapies.

